Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 59.35
+0.50 (0.85%)
Apr 29, 2026, 3:00 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 24.02 billion as of April 29, 2026. Its market cap has decreased by -24.29% in one year.
Market Cap
24.02B
Enterprise Value
23.18B
Revenue
3.70B
Ranking
n/a
PE Ratio
23.35
Stock Price
59.35
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 24.02B, an increase of 67.28%. That is a compound annual growth rate of 8.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yili Chuanning Biotechnology | 21.94B |
| BrightGene Bio-Medical Technology | 26.27B |
| Hualan Biological Engineering | 26.43B |
| Suzhou Zelgen Biopharmaceuticals | 26.47B |
| Beijing Tiantan Biological Products | 28.63B |
| Sinocelltech Group | 19.51B |
| Mabwell (Shanghai) Bioscience | 16.50B |
| Chongqing Zhifei Biological Products | 35.74B |